• Journal of Animal Science and Technology
• /
• 제51권2호
• /
• pp.163-170
• /
• 2009

초유는 신생 송아지에게 완전식품으로 제공된다. 반추동물에서 초유는 송아지에게 처음 제공되는 후천적 면역물질의 유일한 공급원이다. 따라서 초유는 반추동물의 숙주방어에서 중요한 역할을 한다. 소의 초유는 신생 송아지에게 처음 24시간 동안 수동 면역물질을 공급하고, 일반적으로 생후 처음 3일 동안 공급된다. 초유는 저장 후 사용을 위해 냉각, 냉동 또는 대기온도에서 발효 또는 화학처리에 의해 보관할 수 있다. 초유관리 조사는 경기와 충남지역에 있는 67개 낙농가로부터 자료 수집을 통하여 조사하였다. 분만 후 5일 동안 생산한 초유의 총 생산량은 평균 80.4 kg이었고, 송아지에게 급여한 포유량은 평균 20.9 kg이었다. 조사결과에 따르면, 남는 초유의 처리방법은 그냥 버린다가 17.9%, 다른 송아지 포유용으로 이용한다가 37.3%, 저장 이용한다가 22.4%, 다른 가축에게 준다가 20.9%, 기타방법으로 처리한다가 1.5%로 확인되었다. 초유의 품질향상을 위해서는 분만전후의 항생제 사용자제와 건유연고의 올바른 선택, 착유 초기동안 착유량을 증대해야 할 것으로 나타났다.

• 한국축산식품학회지
• /
• 제37권1호
• /
• pp.1-9
• /
• 2017

The rotavirus-induced diarrhea of human and animal neonates is a major public health concern worldwide. Until recently, no effective therapy is available to specifically inactivate the rotavirion particles within the gut. Passive immunotherapy by oral administration of chicken egg yolk antibody (IgY) has emerged of late as a fresh alternative strategy to control infectious diseases of the alimentary tract and has been applied in the treatment of diarrhea due to rotavirus infection. The purpose of this concise review is to evaluate evidence on the properties and performance of anti-rotavirus immunoglobulin Y (IgY) for prevention and treatment of rotavirus diarrhea in human and animal neonates. A survey of relevant anti-rotavirus IgY basic studies and clinical trials among neonatal animals (since 1994-2015) and humans (since 1982-2015) have been reviewed and briefly summarized. Our analysis of a number of rotavirus investigations involving animal and human clinical trials revealed that anti-rotavirus IgY significantly reduced the severity of clinical manifestation of diarrhea among IgY-treated subjects relative to a corresponding control or placebo group. The accumulated information as a whole depicts oral IgY to be a safe and efficacious option for treatment of rotavirus diarrhea in neonates. There is however a clear need for more randomized, placebo controlled and double-blind trials with bigger sample size to further solidify and confirm claims of efficacy and safety in controlling diarrhea caused by rotavirus infection especially among human infants with health issues such as low birth weights or compromised immunity in whom it is most needed.

• 대한수의학회지
• /
• 제38권4호
• /
• pp.837-842
• /
• 1998

The present study describes the effectiveness of egg yolk antibodies (IgY) against enteric colibacillosis and edema disease in piglets. The antibodies were gained from the egg yolk of hens immunized with k88, k99, 987p fimbrial adhesin and heat-labile toxin antigens of enterotoxigenic Escherichia coli (ETEC). Orally-administered egg yolk antibodies solution protected against experimental challenge with ETEC $K88^+$ and $k99^+$ strains in neonatal piglets and mice. In field trial, a total of 598 diarrheal piglets were orally treated with 3ml of antibody once a day to determine for the therapeutic effect. Of them, 582 (97.3%) piglets were recovered from diarrhea in 3 days. We also experimentally treated with the egg yolk antibodies twice a day for 5 consecutive days for 94 weaning piglets with edema disease for the determination of therapeutic effects. Seventy four piglets (78.7%) were recovered from clinical edema signs. Theses findings indicate that egg yolk antibodies against k88, k99, 987p and LT of ETEC are useful source of passive immunity for enteric colibacillosis and edema disease of piglets.

• 한국정보처리학회논문지
• /
• 제2권1호
• /
• pp.95-105
• /
• 1995

광전송에 의한 광통신 기술의 사용이 보편화 되면서 MAP 3.0규격은 광 파이버의 전송시 잡음 여유, 열악한 환경에서의 정상 동작, 안정성, 고속 전송의 장점 등으로 전송 매체로서 선택 사양에 규정하고 있다. 이러한 특성들은 제조 환경에서 광 네트워 크를 구축하는 것에 유용하다. 본 논문에서는 버스와 스타 구조의 사용을 포함한 광 패버 802.4의 MAP 네트워크 시스템 구축에 대하여 해석하고 광 패시브스타 네트워크와 FDDI 네트워크 모델을 제안 하였다. 그리고, MAP 규격의 물리 및 데이타 링크 계층 구 조에서 100 Mbps의 이중 링 구조의 FDDI 프로토콜을 제조 환경에서의 특성을 해석 하 였다. 또한 제조 환경에서 제안된 두 모델에 대하여 응용 서비스, 실시간 처리성, 토 폴로지면에서 비교하고 평가하였다.

• Parasites, Hosts and Diseases
• /
• 제23권1호
• /
• pp.151-155
• /
• 1985

CGVS 배지에서 무균 배양한 Naegleria fowleri 영양형을 5% formaldehyde로 고정시켜 $1{\times}10^6$개씩 일주일 간격으로 3회 또는 6회 BAKA/c 마우스 복강내에 주입시켜 면역시켰다. 면역이 끝나고 7일후 배양된 N. fowleri영양형 $5{\times}10^4$개를 secobarbital로 마취된 마우스 비강에 떨어뜨려 감염시켰다. 어미 마우스에만 또는 어미와 그 새끼 마우스에 모두 면역시켰을 때, N. fowleri 감염에 의한 사망율에 있어 대조군과 차이가 없었으나 그 생존기간은 연장됨을 알 수 있었다. 그러나 새끼마우스에만 면역시켰을 때 사망율이 현저히 감소하였고 생존기간도 훨씬 연장되었다. 새끼 마우스에만 면역시켰을 때 방어면역 효과가 현저하였으나, 어미 마우스에만 또는 면역시킨 어미로부터 태어난 새끼 마우스에 면역시켰을 때는 방어면역이 나타나지 않음을 알 수 있었다.

• 한방안이비인후피부과학회지
• /
• 제4권1호
• /
• pp.1-22
• /
• 1991

The object of this research is to find out the clinical effects of Sopungsan and Gamisopungsan on Immune response and the An1i-allergic reaction to rats and mice. The results obtained are as follows: 1. Both sopungsan and Gamisopungsan have a tendency to decrease on the delayed type hypersensitivity response in methotrexate treated mice, but are not recognized as having significance. 2. Both Sopungsan and Gamisopungsan reveal the increasing effects with significance on the hemagglution titer in mice. 3. Gamisopungsan reveals the increasing effect with significance on the hemolysin titer in mice. 4. Both Sopungsan and Gamisopungsan have a tendency to increase on the appearance of Rosette forming cells in mice, but are not recognized as having significance. 5. Both Sopungsan and Gamisopungsan reveal the increasing effects with significance on phagocytic index K and a in mice 6. Sopungsan reveals the decreasing effect, on the homologous passive cutaneous anaphylaxis in rats provoked by the IgE-like antibody aganist egg white albumin. 7. Gamisopungsan reveals the decreasing effect with significance on vascular permeabi1ity response to intradermal histamin in rats. 8. Sopungsan reveals the decreasing effect with significance, on vascular permeability response to intradermal serotonin in rats. 9. Both Sopungsan and Gamisopungsan reveal the decreasing effects with significance on the delayed type hypersensitivity response to picryl chloride in mice. 10. Both Sopungsan and Gamisopungsan reveal the decreasing effects with significance on the delayed type hypersensitivity response to sheep red blood cell in mice. According to the above results, Sopungsan and Gamisopungsan are concluded to have the increasing effect of immunity and anti-allergic reaction.

• Journal of Animal Science and Technology
• /
• 제63권5호
• /
• pp.1114-1125
• /
• 2021

Supplying a sufficient amount of high-quality colostrum is a prevailing challenge in Hanwoo calf production systems. This study aimed to describe the efficiency of a lacteal-derived colostrum replacer versus natural bovine colostrum (from Holstein) fed to Hanwoo calves. Forty newborn Hanwoo calves (25 males and 15 females; 30.7 ± 3.15 kg body weight [mean ± standard deviation]) were blocked by sex and birth weight and fed either natural colostrum or a commercial colostrum replacer. Calves displayed a narrow difference in the evolution of body weight and structural body dimensions when they received a commercial versus natural colostrum. Minor differences existed in the starter and total dry matter consumption between calves fed natural or commercial colostrum. Although the colostrum source had no significant effects on days to first diarrhea (average of 7.6 days; p = 0.17), the duration of diarrhea was longer in natural colostrum-fed calves (3.2 vs. 4.5 days; p = 0.04). Consumption of natural colostrum resulted in greater mean serum immunoglobulin G (IgG) on day 2 (14.7 vs. 10.8 ± 0.92 mg/mL) and day 7 (8.21 vs. 5.12 ± 0.82 mg/mL) of calf life, resulting in a greater proportion of commercial colostrum-fed calves (50% vs. 15%; day 2) to experience failure of passive transfer of immunity (serum IgG < cutoff point of 10 mg/mL). Overall, growth rate, body frame development, and incidence of diarrheal disease were not different in both groups. These results suggested that the colostrum replacer product tested in this study could be an alternative to natural colostrum derived from Holstein cow in securing calf growth and health in Hanwoo calf-rearing operations.

• 대한수의학회지
• /
• 제29권2호
• /
• pp.83-90
• /
• 1989

The changes in serum total protein and immunoglobulin levels, and BVD, IBR and PI-3 viral neutralizing antibody titers in colostrum-conferred Korean native calves during the first 12 weeks postpartum were studied, and the results obtained were summerized as follows: The Mean concentration of total protein, total immunoglobulin, IgG, IgM and IgA in sera of 9 calves at birth were $3.8{\pm}0.5g/dl$, $0.27{\pm}0.15mg/ml$, $0.06{\pm}0.08mg/ml$, $0.21{\pm}0.11mg/ml$, and extremely low concentration, respectively. Serum total protein level reached a maximum at 20 hours after birth, total immunoglobulin, IgG, and IgM levels at 24 hours, and IgA level at 28 hours, respectively. Serum IgA level reached a minimum at 4 weeks old, IgM level at 5 weeks, total immunoglobulin level at 8 weeks, and IgG level at 10 weeks, respectively. After then those levels had begun to increase, but total protein level was still decreasing at 12 weeks old. The half-lives of IgG, IgM, and IgA were 21.1 days, 4.0 days, and 2.6 days-respectively. In 10 Korean native cows immediately after parturition, serum neutralizing antibody titers specific to BVD, IBR and PI-3 virus were $8.7{\pm}1.5{\log}_2$, $5.7{\pm}1.2{\log}_2$, and $6.8{\pm}1.01{\log}_2$, respectively. And colostral neutralizing antibody titers against BVD, IBR, and PI-3 virus were $10.1{\pm}1.4{\log}_2$, $6.8{\pm}1.3{\log}_2$ and $7.8{\pm}1.7{\log}_2$, respectively. Before suckling the colostrum, SN antibody titers against BVD, IBR, and PI-3 virus were undetectable from all of 9 Korean native calves. Nevertheless SN antibody titer against BVD virus reached a maximum level ($9.2{\pm}0.6{\log}_2$) at 24 hours after birth, that against IBR virus ($6.1{\pm}1.0{\log}_2$) at 20 hours after birth, and that against PI-3 virus ($6.8{\pm}0.9{\log}_2$) at 32 hours after birth, respectively. In 12 weeks old calves, the SN antibodies against BVD and IBR virus were still decreasing, but that against PI-3 virus reached a minimum at 10 weeks, and increased after 12 weeks of age. The half-lives of SN antibodies against BVD, PI-3 and IBR, virus were 16.0 days, 22.6 days, and 25.5 days, respectively.

• Parasites, Hosts and Diseases
• /
• 제27권2호
• /
• pp.79-86
• /
• 1989

Naegleria fowleri로 면역시킨 마우스의 혈청이나 비장세포를 다른 마우스에 주입시켜 N. fowleri 감염에 대한 면역효과가 나타나는지 살펴보았다. 또 어미 마우스를 N. fowleri로 면역시 킨 다음 면역시키지 않은 어미에서 태어난 새끼 마우스에게 면역시킨 마우스의 모유를 먹게한 뒤 모유를 통한 면역 효과의 전달 여부를 관찰하였다. 면역시킨 마우스의 비장세포나 정상 마우스의 혈청을 다른 마우스에 주입시킨 경우 감염 후 사망률이 감소하였으나 혈중 IgG는 증가되지 않았다. 한편, 면역시킨 마우스의 혈청이나 정상 마우스의 비장세포를 준 경우 혈중 보G가 증가되고 감염 후 생존 기간은 연장되었으나 결국은 모든 마우스가 사망하였다. 즉 면역시킨 마우스 또는 정상 마우스의 혈청이나 비장세포를 다른 마우스에 주입시키면 사망률이 감소되거나 생존 기간이 연장됨을 알 수 있었다. 또 면역시킨 어미 마우스의 혈중, 모유 내, 또는 그 모유를 먹은 새끼 마우스의 혈 중에서, N. fowleri에 대한 IgG는 증가되었으나 IgA는 증가하지 않았으며 증가된 항체도 감염 후 의 사망률이나 생존 기간에는 큰 영향을 주지 않았다.

• Pediatric Infection and Vaccine
• /
• 제3권2호
• /
• pp.185-193
• /
• 1996

Purpose : The incidence of measles was gradually decreased since 1963 when measles vaccination was firstly developed and liscenced in the world. But, recently the outbreaks of measles in infants and school children have been reported despite of wide spread use of measles vaccination. This study was performed to evaluate the efficacy of measles vaccination and the necessity of revaccination in Korean infants and children. Methods : 168 subjects of mothers and neonates, infants and children were enrolled in this study during the periods of 10 months from March to December in 1995. Measles specific IgG in the sera of mothers and children was measured using EIA kit (Sigma Co., MO, USA). Antibody titer of over or equal to 110 AU/ml was considered positive. Results : The results obtained were as follows. 1) Values of measles specific IgG in the sera of mother and neonate were 82.9 AU/ml and 89.3 AU/ml respectively and were rapidly decreased within 6 month after birth. Positive antibody levels (${\geq}$ 110 AU/ml) were observed in only 25 % of neonates. 2) In vaccinated children, values of measles specific IgG were 117.4 AU/ml in 9~15 month group, 76.9 AU/ml in 3~6 year group and 79.5 AU/ml in 10~15 year group after either one or two times of measles vaccination. Positive antibody levels in vaccinated children were observed in 57.7% of 9~15 month group, 38.4% of 3~6 year group and 34.7% of 10~15 year group. Conclusion : These results suggest that primary measles vaccination before 6 months of age can be considered and revaccination of measles should be recommended before 3~6 years of age. Further studies will be needed to clarify the reasons of high proportion of primary measles vaccination failure and to established the appropriate schedule of measles vaccination in korean infants and children.